PAXIP1 and major depressive disorder: Importantly, behavioral abnormalities were notably more pronounced in female mice, consistent with clinical observations of female‐specific upregulation of PAXIP1‐AS1 expression in the PFC of patients with MDD, and with known sex‐biased vulnerability and symptom profiles in mood and psychotic disorders.